GLP-1s may work by activating an unlikely weight loss ally

Recent research suggests that GLP-1 medications may facilitate weight loss by activating specific hunger-regulating neurons. While the study provides new insights into the biological mechanisms behind these drugs, researchers noted that direct testing of these neurons in living human subjects remains currently impossible.

The study's authors intend for these findings to serve as a foundation for future scientific inquiry. By better understanding how these neurons respond to treatment, researchers hope to develop more effective weight loss therapies.